SAVA – Knox Daily

Analysts Viewpoint

Cassava Sciences Inc’s recent filing unveils that its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cassava Sciences

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cassava Sciences

Analysts Viewpoint

In a filing, Cassava Sciences Inc revealed its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0

Analysts Viewpoint

In a filing, Cassava Sciences Inc revealed its Chief Medical Officer Kupiec James William unloaded Company’s shares for reported $15480.0

Featured

Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed

Featured

The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a

Tag: SAVA